Timothy Stephen Clifford Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Broadway, Bucksport, ME 04416 Phone: 207-469-7371 Fax: 207-469-7306 |
Dr. Cindy E Pepper, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Broadway, Bucksport, ME 04416 Phone: 207-469-7371 |
Dr. Karen Calcott, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 Broadway, Bucksport, ME 04416 Phone: 207-469-7371 Fax: 207-469-7306 |
Stanley L Whittemore Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 Broadway, Bucksport Regional Healthcenter, Bucksport, ME 04416 Phone: 207-469-7371 Fax: 207-469-7306 |
Beth Ann Lieberman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Broadway, Bucksport, ME 04416 Phone: 207-469-7371 |
Christopher Jastram, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Broadway, Bucksport, ME 04416 Phone: 207-469-7371 |
News Archive
A genetic mutation that can raise the amount of glucose in a person's blood to harmful levels is identified today in a study in the journal Science.
A study released this week suggests that anti-cancer chemotherapies which use nanoparticles to deliver drugs deep inside tumor tissue will be more effective if the particles are positively electrically charged because they are taken up to a greater extent by proliferating cells, according to a team of chemists and chemical engineers at the University of Massachusetts Amherst.
Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
A tiny snail may offer an alternative to opioids for pain relief. Scientists at the University of Utah have found a compound that blocks pain by targeting a pathway not associated with opioids.
› Verified 9 days ago